EXEL - EXELIXIS, INC.
IEX Last Trade
33.885
-0.040 -0.118%
Share volume: 30,500
Last Updated: Fri 27 Dec 2024 08:30:06 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$33.92
-0.04
-0.12%
Summary score
36%
Profitability
35%
Dept financing
23%
Liquidity
67%
Performance
33%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.02%
Return on assets
1.84%
Return on sales
12.2%
Return on invested capital
6.86%
Total debt ratio
16.4%
Debt ratio change over timeo
17.66%
Current Ratio
5.77%
Quick Ratio
5.68%
Cash Position Ratio
4.76%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
2.2%
Return on assets
1.72%
Return on sales
11.14%
Return on invested capital
4.25%
Total debt ratio
21.96%
Debt ratio change over timeo
61.08%
Current Ratio
3.83%
Quick Ratio
3.77%
Cash Position Ratio
2.94%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
1.75%
Return on assets
2.22%
Return on sales
14.65%
Return on invested capital
3.28%
Total debt ratio
24.1%
Debt ratio change over time
2.47%
Current Ratio
3.46%
Quick Ratio
3.41%
Cash Position Ratio
2.58%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-73.2%
Return on assets
-126.06%
Return on sales
-272.18%
Return on invested capital
-34.22%
Total debt ratio
1765.52%
Debt ratio change over time
17.66%
Current Ratio
437.57%
Quick Ratio
430.04%
Cash Position Ratio
344.08%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EXEL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 2.02% | 13.79% | 34.47% | 7.43% |
| Return on assets | 1.84% | 2.76% | 3.15% | 5.62% |
| Return on sales | 12.2% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 6.86% | 2.36% | 5.39% | 19.77% |
| Profitability | 26% | 43% | 66% | 80% |
| Total debt ratio | 16.4% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | 17.66% | 308.97% | -6.99% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 3.83% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.77% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.94% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 9% | 20% | 47% |
| Short-term ratios | EXEL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 2.2% | 13.77% | 13.25% | 3.8% |
| Return on assets | 1.72% | 2.43% | 1.89% | 3.09% |
| Return on sales | 11.14% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 4.25% | 2.14% | 3.39% | 9.18% |
| Profitability | 39% | 71% | 68% | 82% |
| Total debt ratio | 21.96% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 61.08% | 46.38% | -72.08% | 1.51% |
| Dept financing | 31% | 44% | 25% | 6% |
| Current Ratio | 3.83% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.77% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.94% | 0.36% | 1.28% | 2.93% |
| Liquididy | 63% | 12% | 31% | 75% |